Nencki Institute of Experimental Biology PAS, Managing Director BTM Mazovia
Marcin Szumowski has graduated from the University of Illinois with an MSc and PhD degrees (in atmospheric physics) and also earned an MBA (in entrepreneurship and international finance). Following a successful research career in the United States, since 2000 he has been involved in technology transfer and set up several start-up companies, including a 2005 high technology start-up (www.medicalgorithmics.com). During the period of 2005-2009 as the president and CEO of Medicalgorithmics he secured over 4 million PLN in private equity investment and nearly 4 million in matching public funds. He was also responsible for its business development during advanced medical diagnostics R&D, with two products cleared for marketing in Europe (CE mark, 2008, 2009) and USA (FDA 510k approval, 2009). In 2010 Medicalgorithmics SA recorded a 1.7 million net profit based on 4.1 million PLN revenue and currently is ranked first of 252 companies listed on the Polish alternative stock exchange "NewConnect" with market capitalization over 250M PLN and high percentage of export sales. Dr. Szumowski has been involved in preparation and management of more than 40 R&D and investment projects with a combined budget of over 200 million euro. Currently he is responsible for establishing a technology transfer platform within a bio-tech-med cluster (BTM Mazovia). BTM Mazovia Cluster is forming around a 100 million euro Centre for Preclinical Research and Technology (CePT) project involving three largest Warsaw universities and seven Polish Academy of Science institutes. It also brings together several biotech and biomed companies, VC and seed funds in partnership with the City of Warsaw.